Abbott Laboratories agreed to pay at least $1.3 billion to settle claims by the U.S. government and 24 states alleging the company illegally marketed its Depakote epilepsy drug, people familiar with the accords said.
AbbVie Inc., an Abbott Laboratories spinoff, will face a new trial of a GlaxoSmithKline Plc lawsuit over an AIDS drug accord after a federal appeals court said Abbott’s lawyers improperly excluded a gay man from the jury.
Swiss banks will likely settle a sweeping U.S. probe of offshore tax evasion by paying billions of dollars and handing over names of thousands of Americans who have secret accounts, Bloomberg News’ David Voreacos, Klaus Wille and Giles Broom report.
T. Mark Jones learned about the costs and benefits of health-care delivery when he treated AIDS patients in Key West, Florida, in the late 1980s. The pharmacy he co-founded -- unusual at the time -- provided a humane last step for gay men who didn’t want to spend their final weeks confined to a hospital.
Impax Laboratories Inc. said it settled patent litigation with Abbott Laboratories and its Fournier Laboratories Ireland Ltd. unit, permitting Impax to sell a generic version of the cholesterol drug TriLipix as early as 2013.